STK3 is a therapeutic target for a subset of acute myeloid leukemias

Acute myeloid leukemia (AML) is characterized by uncontrolled proliferation and accumulation of immature myeloblasts, which impair normal hematopoiesis. While this definition categorizes the disease into a distinctive group, the large number of different genetic and epigenetic alterations actually s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Camgoz, Aylin, Paszkowski-Rogacz, Maciej, Satpathy, Shankha, Wermke, Martin, Hamann, Martin V., von Bonin, Malte, Choudhary, Chunaram, Knapp, Stefan, Buchholz, Frank
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5986655/
https://ncbi.nlm.nih.gov/pubmed/29876001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25238
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars